BiotechTube
Home/Pipeline/Pancreatic Cancer Detection Device

Pancreatic Cancer Detection Device

Pancreatic Cancer

DevelopmentPreclinical/Clinical Studies

Key Facts

Indication
Pancreatic Cancer
Phase
Development
Status
Preclinical/Clinical Studies
Company
Craif

About Craif

Craif develops AI-powered, non-invasive cancer detection tests using urine and saliva biomarkers to shift healthcare from treatment to prevention.

View full company profile

Therapeutic Areas

Oncology

Other Pancreatic Cancer Drugs

DrugCompanyPhase
Ampligen® (rintatolimod)AIM ImmunoTechEarly Access Program
HBM9027Harbour BioMedPhase 1
Small-Molecule TherapeuticAIkido LabsPre-clinical
AHPBA IRE RegistryAngioDynamicsPost-Market Registry
SIMBs + ImmunotherapyAdvanced MicrobubblesPre-clinical
CLS-014CLS TherapeuticsPre-clinical
SOMA PlatformCoherence NeuroPre-clinical
NP-G2-044Novita PharmaceuticalsPhase 2a
Pritumumab (PTB)Nascent BiotechPhase II (Planned)
Pancreatic Cancer TestMosaique DiagnosticDevelopment
Iontophoretic SystemContinuity BiosciencesPre-clinical
Lixumistat (IM156)ImmunoMet TherapeuticsPhase 1b